Hi reader, we recently came across a very small yet promising nanocap and wanted to share our work with you as soon as possible. So, we’re releasing December’s PrudentIdea early. Since it’s a nanocap, it demands an extra level of patience. We hope you enjoy reading our final PrudentIdea of 2025 😊
Contents:
- About the company
- About the management
- Business Model
- Therapeutic segments and dosage forms offerings
- Manufacturing Plant and capacities
- Capacity Utilisation by Therapeutic Offerings
- Market opportunity size
- Financials
- Guidance
- Risks
- Valuations
- Why do we find the company interesting?
About the company
Incorporated in 2012, Accretion Pharmaceuticals Limited (Mcap 89 Cr) is a pharmaceutical company that manufactures and sells tablets, capsules, and other healthcare products.
About the Management
Business Model
To read the full article, please subscribe to PRUDENT Ideas Membership!
See you next time.
Until then… Stay Prudent!
Disclaimer: This article is provided for informational purposes only and should not be considered as an investment advice
Also Read: